MedTrace Logo

Risk Stratification and Early Alerting Regarding COVID-19 Hospitalization

NCT04709068 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 8

Last updated 2024-09-19

Study results available
· View outcomes & findings →

Summary

The purpose of this research is to remotely monitor individuals who have tested positive for COVID-19 to learn more about progression and recovery from the disease. Individuals who test positive for COVID-19 will wear the Current Health wearable device continuously and answer a brief series of questions on Current Health tablet daily for up to 30 days. The health data will be used to develop predictive models of hospitalization risk.

Conditions

  • Covid19

Interventions

DEVICE

Current Health

wearable device and tablet used to collect health measures at home

Sponsors & Collaborators

Principal Investigators

  • Adam Wolfberg, MD · Current Health

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-08
Primary Completion
2021-05-03
Completion
2021-06-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04709068 on ClinicalTrials.gov